THERAPY Liraglutide: preventing or postponing T2DM diagnosis?
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Standard
THERAPY Liraglutide : preventing or postponing T2DM diagnosis? / Vilsboll, Tina; Knop, Filip K.
I: Nature Reviews Endocrinology, Bind 13, 2017, s. 320-322.Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Vilsboll, T & Knop, FK 2017, 'THERAPY Liraglutide: preventing or postponing T2DM diagnosis?', Nature Reviews Endocrinology, bind 13, s. 320-322. https://doi.org/10.1038/nrendo.2017.55
APA
Vilsboll, T., & Knop, F. K. (2017). THERAPY Liraglutide: preventing or postponing T2DM diagnosis? Nature Reviews Endocrinology, 13, 320-322. https://doi.org/10.1038/nrendo.2017.55
Vancouver
Vilsboll T, Knop FK. THERAPY Liraglutide: preventing or postponing T2DM diagnosis? Nature Reviews Endocrinology. 2017;13:320-322. https://doi.org/10.1038/nrendo.2017.55
Author
Bibtex
@article{8d58d4ce69654449814cddfebd5d2c23,
title = "THERAPY Liraglutide: preventing or postponing T2DM diagnosis?",
author = "Tina Vilsboll and Knop, {Filip K.}",
year = "2017",
doi = "10.1038/nrendo.2017.55",
language = "English",
volume = "13",
pages = "320--322",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "nature publishing group",
}
RIS
TY - JOUR
T1 - THERAPY Liraglutide
T2 - preventing or postponing T2DM diagnosis?
AU - Vilsboll, Tina
AU - Knop, Filip K.
PY - 2017
Y1 - 2017
U2 - 10.1038/nrendo.2017.55
DO - 10.1038/nrendo.2017.55
M3 - Comment/debate
C2 - 28474687
VL - 13
SP - 320
EP - 322
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
SN - 1759-5029
ER -
ID: 188531708